Drug intelligence / Profile preview

intact casein

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Intact casein is the primary, naturally structured protein found in milk and dairy products. It is characterized as a 'slow-digesting' protein because it forms a gel or clot (micellar structure) in the acidic environment of the stomach. This property delays gastric emptying and results in a gradual, sustained release of amino acids into the bloodstream over several hours. Due to its slow absorption kinetics, intact casein is investigated for its potential health benefits, including enhancing satiety, reducing overall food intake, and modulating metabolic rate, which may aid in weight management and obesity prevention. It is often contrasted in clinical studies with 'fast-digesting' proteins like whey and hydrolyzed casein to understand how protein absorption speed influences muscle protein synthesis, appetite-regulating hormones (e.g., GLP-1), and substrate oxidation. Research has also explored its role in mitigating age-related muscle loss (sarcopenia) and its effects on metabolic health in individuals with obesity or metabolic syndrome.

Brand names
Miprodan 30Miprodan30Miprodan-30
Other names
caseinmicellar caseincalcium caseinatesodium caseinate

Beyond the preview

Go deeper on intact casein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on intact casein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call